A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This is a randomised, open-label; parallel group, multicentric study comparing the efficacy
and safety of fixed-dose-combinations of Metoprolol XL plus Amlodipine with individual
components of the combination. SelomaxTM50/5 will also be compared with SelomaxTM 25/2.5 in
lowering of BP (SBP and DBP) in Indian patients with essential hypertension.Male and female
patients of essential hypertension aged between 18-80 years will be studied. The patients
should not have a history of prior cardiovascular disease.